Views & Analysis Addressing market access obstacles for rare bleeding disorde... Scrutiniseing the market access situation for people with rare bleeding disorders.
Partner Content Partner Content How to fix your adherence problem Typical patient support programs fail to improve adherence - and it’s costing the pharma industry billions. Here’s how to do a better job.
Views & Analysis Rare disease market research needs a multifaceted approach Challenges in rare disease market research and the role of online research.
Views & Analysis What does your pharma brand mean to patients? Pharma companies can differentiate themselves and win support if they take actions that patients find informative.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
